Where does Whitehead Institute For Biomedical Research rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Whitehead Institute For Biomedical Research ranks #3,002 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Whitehead Institute For Biomedical Research hold?

Whitehead Institute For Biomedical Research holds 127 US utility patents granted between 2015 and 2025, spanning 21 technology areas.

What is Whitehead Institute For Biomedical Research's Innovation Score?

Whitehead Institute For Biomedical Research has an Innovation Score of 54.4 out of 100 (top 8% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Whitehead Institute For Biomedical Research's patent grant rate increasing or decreasing?

Whitehead Institute For Biomedical Research's recent grant velocity is -28% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Whitehead Institute For Biomedical Research's patents?

Whitehead Institute For Biomedical Research's patents average 18.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView US Corporation

Whitehead Institute For Biomedical Research

Q: What technology areas does Whitehead Institute For Biomedical Research focus on?

Whitehead Institute For Biomedical Research's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 86 patents, ranking #109 of 4,144 assignees active in that subclass. Grants appear in 21 CPC subclasses total.

Q: How is the Whitehead Institute For Biomedical Research patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 127 granted patents across 21 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Whitehead ranks #3,002 of 49,997 tracked US assignees by granted-patent volume, with 127 patents across 21 technology areas.

#3,002
of 49,997 US assignees by volume: Top 8%
by Innovation Score (54.4/100): 18.8
avg claims per patent: -28%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3002 · US Corporation #3,002 · 127 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 127 grants
TOP-DECILE #3,002/49,997
PHOTO-FINISH Universite Pierre…
CPC-FOCUS C12N · 21 areas
INNOV-PAR 54.4/100
CLAIMS-RICH 18.8 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -28% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Universite Pierre Et Marie Curie (Paris 6) (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Whitehead’s 54.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.8 pts (31%) Velocity 10.1 pts (19%) Breadth 16.2 pts (30%) Claim depth 11.3 pts (21%)

Qualcomm Incorporated · highest

85
Secure Identity · near

54
Whitehead Institute… · this assignee

54
China University of… · near

54
Intel Deutschland · near

54
Pella · near

54
3D Lighting… · lowest

7

What this shows Whitehead's Innovation Score is 54.4/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Whitehead?

Each dot is one of Whitehead’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Whitehead’s own 18.8 claims/patent is ABOVE the 15.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Whitehead vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Whitehead's grants concentrate

Whitehead Institute For Biomedical Research is a focused PatentsView assignee: 21 CPC subclasses with 67.7% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2015 (19 grants) versus a trough of 5 in 2020. By volume, Whitehead sits between Universite Pierre Et Marie Curie (Paris 6) and Ceres, Inc..

Whitehead's three-year grant acceleration

From 2019–2021 to 2022–2024, Whitehead Institute For Biomedical Research moved from 23 to 35 grants (1.52x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #434. See the growth leaderboard.

Universite Pierre…

127
Vodafone IP Licen…

127
W Kordes' SÖHNE R…

127
Wangsu Science AN…

127
Wyeth

127
Whitehead Institu… ◀

127
Abb Vie Deutschla…

126
Chatsworth Produc…

126
Ceres

126

What this shows Whitehead holds 127 patents at rank #3,002, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Whitehead

By rank, the assignees closest to #3,002 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Whitehead's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Whitehead, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Whitehead ranks #109 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (54 here).

Secure Identity, LLC 54 China University of Petroleum—Beijing 54 Intel Deutschland GmbH 54 Pella Corporation 54

Similar claim depth

Nearest assignees by average claims per patent (18.8 here).

3shape A/S 18.8 avg Idexx Laboratories Inc. 18.8 avg Genzyme Corporation 18.8 avg Kaseya Limited 18.8 avg

Whitehead's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Whitehead Institute For Biomedical Research patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	19	15.0%
2016	9	7.1%
2017	18	14.2%
2018	13	10.2%
2019	9	7.1%
2020	5	3.9%
2021	9	7.1%
2022	16	12.6%
2023	9	7.1%
2024	10	7.9%
2025partial year	10	7.9%

Which technologies does Whitehead Institute For Biomedical Research patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 86

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 61

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 56

C07K - Peptides 49

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 45

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 30

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 29

C12Y - Enzymes 18

C07D - Heterocyclic Compounds 9

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 7

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 7

Y02A - Technologies FOR Adaptation TO Climate Change 5

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 3

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

Top 15 of 21 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Whitehead Institute For Biomedical Research's patent record in context - here's where to go next.

Whitehead Institute For Biomedical Research's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 67.7% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #3,002 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Whitehead Institute For Biomedical Research against Universite Pierre Et Marie Curie (Paris 6), an assignee filing at a similar volume. Compare portfolios
Innovation Score of 54.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.